NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea · Delayed Price · Currency is KRW

17,170

-10 (-0.06%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Personal Products	132.18B	119.01B	97.10B	85.03B	87.93B
Personal Products Growth	11.07%	22.56%	14.20%	-3.30%	7.72%
Total	132.18B	119.01B	97.10B	85.03B	87.93B
Total Growth	11.07%	22.56%	14.20%	-3.30%	7.72%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	108.12B	101.93B	83.00B	74.74B	79.14B
South Korea Growth	6.07%	22.81%	11.04%	-5.55%	4.36%
Europe	8.96B	7.34B	4.85B	-	-
Europe Growth	21.99%	51.32%	-	-	-
Asia	13.46B	8.34B	8.77B	-	-
Asia Growth	61.31%	-4.92%	-	-	-
North America	1.65B	1.40B	482.84M	-	-
North America Growth	17.85%	189.91%	-	-	-
Export	-	-	-	10.29B	8.79B
Export Growth	-	-	-	17.01%	51.73%
Total	132.18B	119.01B	97.10B	85.03B	87.93B
Total Growth	11.07%	22.56%	14.20%	-3.30%	7.72%

Source: S&P Global Market Intelligence.